Nicholas Investment Partners, LP Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001389574
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q3 2023 · 167 positions · Total reported value $1.23B · Top-10 concentration 28.6% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 65.3% · 46 new · 71 cut · 37 exited
Active Share (vs S&P 500): 82.9% · vs QQQ: 85.0% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -15.0% · vs SPY -17.1% · Prev Value $1.59B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -6.1% · vs SPY -8.2% · Latest Value $1.34B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q3 2023 13F filing, Nicholas Investment Partners, LP disclosed 167 equity positions with a combined reported value of $1.23B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 28.6% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.
The largest disclosed positions as of Q3 2023 were ARGX ($46.00M), KRYS ($41.25M), LEGN ($39.83M). By sector, the heaviest allocations are Health Care 39.4%, Technology 15.4%.
Versus the prior quarter, Nicholas Investment Partners, LP opened 46 new positions, trimmed 71 and fully exited 37, a turnover rate of 65.3% of positions.
The largest new positions opened in Q3 2023 were ARGX ($46.00M), KRYS ($41.25M), LEGN ($39.83M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q3 2023)
- ARGX ARGENX SE · $46.00M
- KRYS KRYSTAL BIOTECH INC · $41.25M
- LEGN LEGEND BIOTECH CORP · $39.83M
- MIRM MIRUM PHARMACEUTICALS INC · $37.90M
- ROIV ROIVANT SCIENCES LTD · $35.02M
- VRTX VERTEX PHARMACEUTICALS INC · $32.95M
- IMGN IMMUNOGEN INC · $32.81M
- ESTA ESTABLISHMENT LABS HLDGS INC · $30.45M
Fully Exited (vs previous quarter)
No tracked position was fully exited this quarter.
Insider Transactions (Form 4)
Latest Nicholas Investment Partners, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Nicholas Investment Partners, LP is an SEC-registered 13F filer based in San Diego, CA, United States. As of Q2 2026 it reported 190 US equity positions with a combined value of $1.59B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: SAN DIEGO, CA, United States
- SEC registration: 801-66532 (status: Approved), registered 2006-04-17
- Regulatory AUM (Form ADV): $1.45B as of 2026-07-10
- Client mix (by RAUM): individual investors 52%, pension and profit-sharing plans 34%
- Manages 3 private funds, of which 2 hedge funds
- Website: nicpartners.com
Portfolio Structure
- 190 positions · $1.59B reported value (Q2 2026)
- Top 10 holdings = 18.6% of reported value
- Largest position: BWXT (BWX TECHNOLOGIES INC COM) at 3.3%
- Average position size: $8.39M
Sector Tilt
- Information Technology 26.9%
- Consumer Discretionary 18.1%
- Industrials 18.0%
- (classified holdings cover 97% of value)
Quarterly Activity
- Q2 2026: 39 new, 79 added, 38 reduced, 40 exited
- 34 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
93.57K | $46.00M | 3.73% | New | |
| 2 |
|
355.61K | $41.25M | 3.35% | New | |
| 3 |
|
593.01K | $39.83M | 3.23% | New | |
| 4 |
|
1.20M | $37.90M | 3.08% | New | |
| 5 |
|
3.00M | $35.02M | 2.84% | New | |
| 6 |
|
94.76K | $32.95M | 2.67% | New | |
| 7 |
|
2.07M | $32.81M | 2.66% | New | |
| 8 |
|
620.62K | $30.45M | 2.47% | New | |
| 9 |
|
854.45K | $29.19M | 2.37% | New | |
| 10 |
|
394.98K | $27.61M | 2.24% | New | |
| 11 |
|
1.84M | $27.43M | 2.23% | New | |
| 12 |
|
2.19M | $26.85M | 2.18% | New | |
| 13 |
|
512.86K | $26.62M | 2.16% | New | |
| 14 |
|
244.93K | $25.22M | 2.05% | New | |
| 15 |
|
460.01K | $23.45M | 1.90% | New | |
| 16 |
|
413.71K | $22.65M | 1.84% | New | |
| 17 |
|
1.16M | $18.96M | 1.54% | New | |
| 18 |
|
104.09K | $17.86M | 1.45% | New | |
| 19 |
|
237.06K | $17.77M | 1.44% | New | |
| 20 |
|
254.75K | $17.70M | 1.44% | New | |
| 21 |
|
150.50K | $17.70M | 1.44% | New | |
| 22 |
|
335.55K | $17.48M | 1.42% | New | |
| 23 |
|
192.69K | $16.56M | 1.34% | New | |
| 24 |
|
454.69K | $16.20M | 1.31% | New | |
| 25 |
|
35.03K | $16.18M | 1.31% | New | |
| 26 |
|
125.32K | $16.09M | 1.31% | New | |
| 27 |
|
92.10K | $15.57M | 1.26% | New | |
| 28 |
|
592.55K | $15.41M | 1.25% | New | |
| 29 |
|
378.15K | $14.52M | 1.18% | New | |
| 30 |
|
81.35K | $13.72M | 1.11% | New | |
| 31 |
|
65.46K | $13.03M | 1.06% | New | |
| 32 |
|
713.83K | $12.55M | 1.02% | New | |
| 33 |
|
268.34K | $12.34M | 1.00% | New | |
| 34 |
|
38.38K | $12.05M | 0.98% | New | |
| 35 |
|
37.86K | $11.95M | 0.97% | New | |
| 36 |
|
476.53K | $10.96M | 0.89% | New | |
| 37 |
|
79.38K | $10.94M | 0.89% | New | |
| 38 |
|
239.67K | $10.90M | 0.89% | New | |
| 39 |
|
24.45K | $10.64M | 0.86% | New | |
| 40 |
|
594.61K | $9.92M | 0.81% | New | |
| 41 |
|
293.02K | $9.80M | 0.80% | New | |
| 42 |
|
219.07K | $9.33M | 0.76% | New | |
| 43 |
|
32.55K | $8.93M | 0.72% | New | |
| 44 |
|
85.50K | $8.80M | 0.71% | New | |
| 45 |
|
83.92K | $8.53M | 0.69% | New | |
| 46 |
|
363.74K | $8.22M | 0.67% | New | |
| 47 |
|
16.61K | $7.62M | 0.62% | New | |
| 48 |
|
135.11K | $7.51M | 0.61% | New | |
| 49 |
|
32.02K | $7.50M | 0.61% | New | |
| 50 |
|
130.99K | $7.12M | 0.58% | New | |
FAQ
What did Nicholas Investment Partners, LP buy in 2023-Q3?
In its 2023-Q3 13F filing, Nicholas Investment Partners, LP reported 167 equity positions worth $1.23B in aggregate; its largest disclosed positions were ARGX ($46.00M), KRYS ($41.25M), LEGN ($39.83M).
How large is Nicholas Investment Partners, LP's portfolio?
Nicholas Investment Partners, LP reported $1.23B of long equity holdings across 167 positions as of 2023-Q3. Top-10 holdings account for 28.6% of reported value.
What is Nicholas Investment Partners, LP's investment style?
HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.